Max M. Quinn

CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation

Jiehui Deng, Eric S. Wang, Russell W. Jenkins et al. · Cancer Discovery · 2017 · 781 citations · Full text

Life Sciences, Immunology, Oncology +17

<i>Ex Vivo</i> Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids

Russell W. Jenkins, Amir Reza Aref, Patrick H. Lizotte et al. · Cancer Discovery · 2017 · 585 citations

Medicine, Immunology, Oncology +17

CDK7 Inhibition Potentiates Genome Instability Triggering Anti-tumor Immunity in Small Cell Lung Cancer

Hua Zhang, Camilla L. Christensen, Ruben Dries et al. · Cancer Cell · 2019 · 224 citations · Full text

Medicine, Cancer Biology, Oncology +12

Targeting <i>HER2</i> Aberrations in Non–Small Cell Lung Cancer with Osimertinib

Shengwu Liu, Shuai Li, Josephine Hai et al. · Clinical Cancer Research · 2018 · 108 citations · Full text

Medicine, Oncology, Pharmacology +17

BET Bromodomain Inhibition Cooperates with PD-1 Blockade to Facilitate Antitumor Response in <i>Kras</i> -Mutant Non–Small Cell Lung Cancer

Dennis O. Adeegbe, Shengwu Liu, Maureen M. Hattersley et al. · Cancer Immunology Research · 2018 · 103 citations · Full text

Medicine, Oncology, Pharmacology +17